Terns Pharmaceuticals to Present Preclinical Data on Two Lead Programs at the European Association for the Study of the Liver (EASL) Annual Meeting 2019
SAN MATEO, Calif. & SHANGHAI, April 1 (Bernama-BUSINESS WIRE) — Terns Pharmaceuticals, Inc. today announced presentation of preclinical data on its two lead programs at The International Liver Congress™ 2019, the Annual Meeting of the European Association for the Study of the Liver (EASL) in Vienna, Austria, April 10-14. TERN-101 reduced…

